Abstract:Two choices are widely used for radiation delivery in China, 3-dimensional conformal radiation therapy (3D-CRT) and conventional external beam radiation and neutron brachytherapy (EBRT+NBT). No randomized comparisons have been conducted in the setting of esophageal cancer. We analyzed two cancer center a large cohort of localized esophageal squamous cell carcinoma (ESCC) patients treated from 3D-CRT to EBRT+NBT to compare outcomes. Patients with ESCC treated with definitive radiation at two institutions between 2002 and 2012 were retrospectively reviewed. Multivariable Cox regression was used to compare oncologic outcomes of NBT+EBRT and 3D-CRT in the context of other clinically relevant variables. Acute and chronic toxicities associated with the 2 techniques were compared using Fisher exact and log-rank tests, respectively. A total of 884 patients were treated during the study period, there were 583 men and 301 women. 339 and 545 underwent 3DCRT NBT+EBRT. The median age was 66 years (range, 36-93 years). Median follow-up time was 32 months, respectively. The overall median survival was 20.3 months. Three and 5-year OS rates were 37.2% and 26.6%, respectively. 5-y LC rate for the whole group was 47.1%. Radiation modality was associated significantly with differences in OS or LC in either multivariable or univariable analyses. To further confirm the treatment modality as a prognostic factor, we compared the two subgroups of patients who were tested to be early-stage (I+II) or advanced stage (III). In the stage I+II group, the 5-year OS and LC rate in the patients who were treated with 3D-CRT were significantly lower than the patients who were treated with EBRT+NBT (with p = 0.004 and 0.045, respectively, for OS and LC). In the stage III group, the differences in 5-year OS rate and LC rate between the two treatment modalities were less obvious (with p=0.306 and 0.175, respectively, for OS and LC). There were 195 recurrences (35.7%), among which 170 (31.2%) were in-field recurrences and 25 (4.6%) were out-of-field recurrences. In terms of acute toxicity, no perforations were observed during this treatment period. Among which the NBT+EBRT group have significantly higher rate of leukopenia and thrombocytopenia (with p<0.001 for both). For late toxicity, fistula and massive bleeding were observed in both groups of patients, of which the 3D-CRT group show higher rate on both effects. In this cohort of patients with ESCC treated with NBT+EBRT were associated with better oncologic outcomes than those of 3D-CRT. NBT+EBRT were associated with a higher rate of acute irradiation toxicity. 3D-CRT has the higher rate of late toxicity esophageal fistulas.

Systematic Review of External Beam Radiotherapy Plus Brachytherapy in Treatment of Patients with Inoperable Esophageal Cancer

A Prospective Study of Radical External Beam Radiotherapy Versus External Beam Radiotherapy Combined with Intraluminal Brachytherapy for Primary Esophageal Cancer

The Role of High-dose-rate Brachytherapy (HDR-BT) in the Radiotherapy of Esophageal Carcinoma

A Retrospective Study of Comparison of Two Common Radiation Therapy Techniques for Definitive Treatment of Localized Esophageal Squamous Cell Cancer

A Meta-analysis of survival of middle and late stage esophageal carcinoma treated with radiotherapy combined with traditional Chinese medicine

External beam radiotherapy with or without californium-252 neutron brachytherapy for treatment of recurrence after definitive chemoradiotherapy

A Clinical Observation of Cf-252 Intracavitary Radiation Combined with External-beam Irradiation in the Treatment of Esophageal Carcinoma

A Prospective Clinical Study of Intracavitary Brachytherapy Combined with External Beam Irradiation for Esophageal Carcinoma

Intraluminal high dose rate brachytherapy combined with external beam irradiation in carcinoma of esophagus

Safety and Outcome of External Beam Radiation and Neutron Brachytherapy in Elderly Patients with Esophageal Squamous Cell Cancer

Systematic Review of Brachytherapy Compared with Stent Placement in Treatment of Dysphagia from Cancer of Esophageal and Gastro-Esophageal Junction

Efficacy and safety of proton radiotherapy combined concurrent chemotherapy for esophageal cancer:a systematic review and Meta-analysis

[Long-term efficacy and safety of simultaneous integrated boost radiotherapy in non-operative esophageal squamous cell carcinoma: a multicenter retrospective data analysis (3JECROG R-05)].

Retrospective analysis on results of late course accelerated hyperfractionation radiotherapy and conventional fractionation radiotherapy plus brachytherapy for esophageal carcinoma

Meta-Analysis of the Effect of Clinical Target Volume for Three Dimensional Conformal Radiotherapy for the Treatment of Esophageal Carcinoma

Efficacy and safety of docetaxel chemotherapy combine with 3-dimensional conformal radiation therapy in treatment of esophageal cancer: a systematic review

Benefits Of Brachytherapy In Addition To External Beam Radiation In Early-Stage Endometrial Carcinoma: Analysis From A Multicenter Study

A Retrospective Study of External Beam Radiation, Neutron Brachytherapy, and Concurrent Chemotherapy for Patients with Localized Advanced Carcinoma of the Esophagus

Clinical Study of Intensity Modulated Radiotherapy Combined with Chemotherapy in the Treatment of Non-surgical Patients with Locally Advanced Esophageal Carcinoma

Do Higher Radiation Doses with Concurrent Chemotherapy in the Definitive Treatment of Esophageal Cancer Improve Outcomes? A Meta-Analysis and Systematic Review